13F filer · CIK 1750183
Antara Capital LP
New York, NY · filing since Q4 2018 · last filing Feb 17, 2026
Reported value
$30.2K
$-460.0K vs prior
Positions
2
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $442.2K
Top-10 weight
100.0%
Biggest buys vs Q3 2025
No new or increased positions this quarter.
Biggest sells vs Q3 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | CURRENC GROUP INC | -263,200 | -100.0% | $-442.2K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ASPIRE BIOPHARMA HLDGS INCCOM | 202,897 | $26.8K | 88.65% |
| 2 | ASPIRE BIOPHARMA HLDGS INC*W EXP 02/14/203 | 207,693 | $3.4K | 11.35% |